ENIOLA OLADOKUN-MEROYI: Open Payments
NPI 1255067047 · RIVERDALE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$175 in 9 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $201 · 2025 $175
Food & beverage: $175
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $33 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| ABBVIE INC. | 1 | $17 |
Products named: INGREZZA, INVEGA SUSTENNA, ABILIFY MAINTENA, VRAYLAR, ABILIFY ASIMTUFII, UZEDY, AUSTEDO XR.
Industry payments across GA — which companies pay providers there.
